Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., Zuardi, A. W.·1990·Psychopharmacology
DOI 10.1007/bf02244012

Cited by (378)

Items 301–378 of 378

  1. The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
    Shahin Jalali · 2013 · International Neuropsychiatric Disease Journal
  2. Comparison between Cannabidiol and Fluoxetine effects on chronic neuropathic pain and depression comorbid in rats
    Débora Thais Pereira Brito, Ana Carolina Medeiros, Christie Ramos Andrade Leite‐Panissi, Evelin Capellari Cárnio, Hélio Rubens Machado, Norberto Cysne Coimbra, Renato Leonardo de Freitas, Priscila Sanjuan de Medeiros · 2025 · Neuroscience and Behavioral Physiology
  3. Stereoselective Synthesis of Cannabidiol and its Unnatural Enantiomer to Evaluate Anxiolytic‐Like Properties and Memory Interactions
    Marcos Accioly, Kawana Rosa, Andressa Gabriela Soliani, Suzete Maria Cerutti, Cristiano Raminelli · 2025 · ChemBioChem
  4. Repeated administration of cannabidiol decreases splenic lymphocyte subset numbers in rats
    T Turkki, Maciej M. Jankowski, Wojciech Glac, Piotr Badtke, Viviane M. Saito, Artur Hugo Swiergiel, Bogna Marta Ignatowska-Jankowska · 2026 · International Journal of Immunopathology and Pharmacology
  5. Cannabidiol for the treatment of positive and negative symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis
    Antonio Di Francesco, Pierfelice Cutrufelli, Cecilia Chiarenza, Luca Zambuto, Carmen Concerto, Ludovico Mineo, Antonino Petralia, Marco Catalfo, Alessandro Rodolico, Myrto T. Samara et al. · 2026 · European Archives of Psychiatry and Clinical Neuroscience
  6. A rodent model of appetitive discrimination with concomitant evaluation of anxiety-like behavior
    Monique Godinho, Alessandra Mussi Ribeiro, Valéria S. Fernandes, Flávio Freitas Barbosa, Ezequiel Batista do Nascimento, Hermany Munguba, Regina H. Silva · 2009 · Journal of Neuroscience Methods
  7. Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis
    Adrieli Oliveira Raminelli, João Luís Q. Simei, Francisco Silveira Guimarães, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa, Flávia L. Osório · 2025 · Cannabis and Cannabinoid Research
  8. Anxiolytic activity of Tribulus terrestris on elevated plus maze
    Saima Ahmed, Sualiha Lutfullah, Izhar Ahmed, Reshma Farooq, Javeid Iqbal · 2014 · Journal of Applied Pharmaceutical Science
  9. Cannabidiol and Cannabis Use Disorder
    María S. García‐Gutiérrez, Francisco Navarrete, Adrián Viudez‐Martínez, Ani Gasparyan, Esther Caparrós, Jorge Manzanares · 2018 · Springer eBooks
  10. O uso de canabinoides no tratamento da ansiedade
    Daniel Zanellati, Vania Rodríguez · 2021 · Revista Brasileira Militar de Ciências
  11. Alcohol, cannabis and tobacco use and the mental health of Australians: a comparative analysis of their associations with other drug use, affective and anxiety disorders and psychosis
    Louisa J Degenhardt, Wayne Hall, Michael T. Lynskey · 2001
  12. Effects of cannabidiol on weight and fasting blood sugar with chronic and subchronic haloperidol administration
    Jaiyeola Abiola Kajero, Soraya Seedat, JUDE UZOMA OHAERI, Abidemi James Akindele, Oluwagbemiga Olanrewaju Aina · 2022 · Discover Mental Health
  13. The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety
    Stanley Lyndon · 2025 · Pharmacopsychiatry
  14. Chronic cannabidiol treatment effects on contextual fear and neuropathic pain in Carioca rats high and low conditioned freezing
    Carolina Macêdo-Souza, Aline Aparecida Ferraresi Tiballi, Silvia Soares Maisonnette, Flávia P. Rosseti, Carlos Henrique Rocha Catalão, Jaime E. C. Hallak, José Alexandre S. Crippa, Antônio Waldo Zuardi, J. Landeira-Fernández, Christie Ramos Andrade Leite‐Panissi · 2025 · Behavioural Brain Research
  15. Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats
    Krittikan Chanpaisaeng, James C. Fleet, Visut Rawiwet, Natthaporn Phonsatta, Atikorn Panya, Nattapon Panupinthu, Narattaphol Charoenphandhu · 2025 · JBMR Plus
  16. The Immunomodulating Effects of Delta-9 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in the Context of Inflammation and Infection in Vitro
    Victor M. Jimenez Jr, Rose D Goodman, Katherine Rouse · 2024 · Journal of Drugs Addiction & Therapeutics
  17. Conhecimento da população universitária sobre o uso farmacológico da Cannabis sativa
    Amanda Silva de Sousa, Beatriz Scarleth Noleto de Souza, Raimundo Nonato Cardoso Miranda, Deyna Francélia Andrade Próspero, Gisele Lopes Cavalcante, Mikaelle Maria Buriti de Sousa Lima, Ana Beatriz Silva Sousa, Raquel Celina Alves de Sousa, Wmayvan Pereira Evangelista De Sousa, Gabriel Silas Borges Silva de Melo et al. · 2019 · Revista Eletrônica Acervo Saúde
  18. From Bud to Brain: A Psychiatrist's View of Marijuana
    Timmen L. Cermak · 2020 · Cambridge University Press eBooks
  19. Anxiety
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
  20. Efeitos do canabidiol no comportamento agressivo induzido por isolamento social em camundongos
    Alice Hartmann dos Santos · 2017
  21. Roadmap For The Expression Of Canonical and Extended Endocannabinoid System Receptors and Proteins in Peripheral Organs of Preclinical Animal Models
    Jose J. Rosado‐Franco, Alysha L. Ellison, CJ White, AS Price, Catherine F. Moore, RE Williams, LB Fridman, Elise M. Weerts, Dionna W. Williams · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Desenvolvimento e validação de metodologia analítica para a determinação de canabidiol e tetraidrocanabinol em amostras de plasma por cromatografia em fase gasosa/espectrometria de massas
    Stefania Pimenta Serrambana Camargo · 2008
  23. Efeitos do canabidiol, um canabinóide derivado da Cannabis sativa, em um modelo murino de inflamação pulmonar aguda: uma avaliação imune-neuro-endocrinológica
    Alison Ribeiro · 2012
  24. Avaliação da administração oral do Canabidiol em voluntátios sadios
    Luiz Carlos Pereira Júnior · 2013
  25. Revista Brasileira de Psiquiatria
    Alexandre Rafael de Mello, Natalia Pinho de Oliveira Ribeiro, Adriana Cardoso de Oliveira, Jaime E. C. Hallak, Cecílio Hallak, José Alexandre, Sylvain V. Crippa, Antônio Egídio Nardi, Antônio Waldo Zuardi · 2012
  26. Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA
    Felipe Villela Gomes · 2016
  27. Subjecffve effects of cannabidiol in anxiety disorder and canabinoid excretion in chronic daily cannabis smokers during sustained abstinence
    Mateus M. Bergamaschi · 2012
  28. Envolvimento do núcleo leito da estria terminal nos efeitos ansiolíticos do canabidiol
    Felipe Villela Gomes · 2011
  29. Efeitos comportamentais do canabidiol em um modelo de psicose induzida por S(+)-ketamina em ratos Wistar
    Jana Batista De Ross · 2017
  30. Efeitos comportamentais e neuroplásticos da combinação de escitalopram e canabinóides
    Franciele Franco Scarante · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  31. Evolução da neurociência comportamental nos últimos 50 anos. Foco no sistema de defesa e na neurotransmissão
    Frederico Guilherme Graeff · 2018 · Medicina (Ribeirão Preto)
  32. Efeitos do canabidiol e escitalopram sobre as diferentes etapas do processo neurogênico hipocampal adulto em camundongos cronicamente estressados
    Vinícius Detoni Lopes · 2019
  33. The innate defensive behaviour and unconditioned fear-induced antinociception evoked by NMDA receptor activation in the medial hypothalamus are modulated by the intradiencephalic treatment with cannabidiol: the role of CB1 cannabinoid receptor
    Asmat Ullah Khan · 2019
  34. Exploring Novel Treatment Approaches for Post-Traumatic Stress Disorder
    Anthony Murkar · 2020 · uO Research (University of Ottawa)
  35. Efeitos da administração aguda do Canabidiol na ansiedade e nos tremores induzidos pelo teste de simulação de falar em público em pacientes com doença de Parkinson
    Stephanie Martins de Faria · 2019
  36. Efeitos do canabidiol e do 7-Nitroindazole na resposta de medo condicionado contextual após exposição de ratos a um estresse intenso: envolvimento dos sistemas nitrérgico, serotoninérgico e canabinoide
    Carla Vila-Verde · 2020
  37. Recrutamento de receptores canabinoides do tipo 1 (CB1) no efeito do canabidiol sobre as respostas defensivas inatas evocadas por camundongos ameaçados por jararacas
    Bruno Mangili de Paula Rodrigues · 2020
  38. Efeitos agudos centrais do canabidiol por meio de neuroimagem funcional e sobre o reconhecimento de emoções faciais em pacientes com transtorno depressivo maior
    Luana Gonçalves Zamarrenho · 2020
  39. Efeitos do Canabidiol na ansiedade induzida pela rememoração do evento traumático, em pacientes com o diagnóstico de transtorno de estresse pós-traumático
    Lívia Maria Bolsoni · 2020
  40. Avaliação dos efeitos do canabidiol sobre as alterações neuroimunoendócrinas e comportamentais induzidas pelo estresse em camundongos
    Alice Hartmann dos Santos · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  41. Cannabinoid-Based Medication
    Timmen L. Cermak · 2020 · Cambridge University Press eBooks
  42. EXCITATORY ACTIONS OF CANNABINOIDS ON VAGAL AFFERENT SIGNALING VIA TRP CHANNELS
    Cody W. Kowalski · 2019 · Research Exchange (Washington State University)
  43. The Science and Art of Healing
    Timmen L. Cermak · 2020
  44. Behavioural and molecular effects induced by Cannabidiol in animal models of depression
    Gabriela Pandini Silote · 2021
  45. Cannabidiol Has a Unique Effect on Global Brain Activity: A Pharmacological, Functional MRI Study in Awake Mice
    Aymen H. Sadaka, Ana Ozuna, Richard J. Ortiz, Praveen Kulkarni, Clare T. Johnson, Heather B. Bradshaw, Bruce S. Cushing, Ai-Ling Li, Andrea G. Hohmann, Craig F. Ferris · 2021 · Research Square
  46. Canabidiol em modelo pré-clínico de dor neuropática: uma avaliação dos aspectos sensoriais, emocionais e inflamatórios relacionados com a modulação da sensibilidade dolorosa
    Gleice Kelli Ribeiro da Silva Cardoso · 2022
  47. Cannabis de grado médico para el tratamiento de la dependencia a Δ-9-Tetrahidrocannabinol
    Federico Pavlovsky, Rafael Groisman, Ana Karina Hurtado, Luciana García · 2022 · Vertex Revista Argentina de Psiquiatría
  48. Caracterização comportamental, eletrofisiológica e celular do abrasamento rápido da amígdala e dos tratamentos com estímulos olfatórios e com HUF-101, um potente análogo do canabidiol
    Polianna Delfino-Pereira · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  49. Caracterização da neuroinvasividade do SARS-CoV-2 e dos efeitos neuroprotetores do canabidiol em um modelo in vitro utilizando o sistema celular SH-SY5Y
    Isabela Pires dos Santos · 2022 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  50. Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556
    Débora Akemi Endo Colodete, Nicole Rodrigues da Silva, João Francisco Cordeiro Pedrazzi, Manoela V. Fogaça, Isadora Lopes Cortez, Elaine Aparecida Del Bel, Aviva Breuer, Raphael Mechoulam, Felipe V. Gomes, Francisco Silveira Guimarães · 2023 · Behavioural Pharmacology
  51. Avaliação dos efeitos do canabidiol sobre as consequências comportamentais induzidas pelo tratamento com o ácido valproico durante o período embrionário do zebrafish
    Karla Cristinne Mancini Costa · 2023
  52. Development of Sequence Characterized Amplified Region Marker for Early Sex Determination of Cannabis sativa L. using Multiplex-Polymerase Chain Reaction
    Gyeong-Ju Gim, Eun Ji Go, Ye Rim Shin, Chang Hyeug Kim, Tae-Hyung Kwon, Joon Hee Han, Young-Seok Lim, Byeong Ryeol Ryu, Jung Dae Lim · 2023 · Korean Journal of Medicinal Crop Science
  53. Participação da NAPE-PLD e de mecanismos de neuroplasticidade do córtex pré-frontal ventromedial nos efeitos antiestresse da combinação de doses subefetivas de canabidiol e escitalopram
    Franciele Franco Scarante · 2023
  54. Avaliação da participação do sistema endocanabinoide na memória de extinção do medo condicionado em camundongos
    Larissa Fernanda Matias Werworn · 2022
  55. A cannabidiol (CBD) oral lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases delta-FosB immunoreactivity in serotonergic cells of the dorsal raphe lateral wings
    Barbara dos Anjos Rosário, Maria P. de Lima, Márcio G. Vieira, Pedro Éverson Alexandre de Aquino, Glauce Socorro de Barros Viana, Edilberto Rocha Silveira, Débora Hellen Almeida de Brito, Dávila Zampieri, Jéssica Alves Lemes, Maria de Fátima Santana de Nazaré et al. · 2023 · Research Square
  56. Discriminative-stimulus effects of cannabidiol oil in Sprague-Dawley rats
    Rebecca L. Chalmé, Michelle A. Frankot, Karen G. Anderson · 2023 · Behavioural Pharmacology
  57. Individual differences in fear extinction learning and the endocannabinoid system
    N.A. Leen · 2024
  58. Efeito do canabidiol sobre as consequências da exposição ao isolamento social prolongado em camundongos fêmeas em diferentes idades: possível envolvimento da via do inflamassoma de NLRP3
    Júlia Oliveira Bilibio · 2024
  59. The chemistry and pharmacology of tetrahydrocannabinol and cannabidiol
    Collins Edward Jana, Tuntufye Mwambyale, George Chirambo, Mayeso N.V. Gwedela, Lifa Chimphepo, Ibrahim Chikowe · 2024 · Elsevier eBooks
  60. Effects of Cannabis in Parkinson's Disease and Other Movement Disorders
    Lara Fernanda de Sá Guimarães, Maria Clara Carvalho Maranho Benicá, Luís Fernando Rosa, Felipe Krieger Vargas, Matheus Pinheiro Tiburcio dos Santos, Carolina Gonçalves, Lucca Pappas Ditleff, Ludmila Fonseca Ruy, Daniel de Almeida Meireles Name, Caio Andrade Prins et al. · 2024 · International Journal of Health Science
  61. Wohlbefinden
    Jamie Peyton, Katherine Kramer, Brook Quesnell, Stephen Niño Cital · 2024 · Springer eBooks
  62. Repeated administration of cannabidiol decreases splenic lymphocyte numbers in rats: involvement of CB 2 receptors
    T Turkki, Maciej M. Jankowski, Wojciech Glac, Piotr Badtke, Viviane M. Saito, Artur Hugo Swiergiel, Bogna Marta Ignatowska-Jankowska · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy
    Delia Soriano, Pablo R. Brumovsky, Marcelo José Villar, Marı́a Florencia Coronel · 2025 · Psychopharmacology
  64. Canabidiol, ansiedade e memórias aversivas: uma revisão das evidências pré-clínicas
    Marina A. M. Portes, Isabel Werle, Luciane Alfaia Soares, Fernanda de Souza Guterres, Leandro Jose Bertoglio · 2025 · Revista Fitos
  65. Effect of Frequency of Prospekta Administration: Anxiolytic Effect in Wistar Rats
    Kirill Svitkin, E. P. Morozova, Anna Krasheninnikova, Elena Kardash, Ksenia Ganina, Alexandra G. Emelyanova, С. А. Тарасов, Oleg I. Epstein · 2025 · Dose-Response
  66. A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe
    Barbara dos Anjos Rosário, Maria Paula de Lima, Márcio G. Vieira, Laís Garret Leite, Pedro Éverson Alexandre de Aquino, Glauce Socorro de Barros Viana, Edilberto Rocha Silveira, Débora Hellen Almeida de Brito, Dávila Zampieri, Nágila Maria Pontes Silva Ricardo et al. · 2025 · Brain Research
  67. Minor cannabinoids CBD, CBG, CBN, and CBC differentially modulate sensory neuron activation
    Katalin Rábl, Larry Gruenke, Ashwin Banfal, Helge Eilers, Judith Hellman, Mark A. Schumacher · 2026 · Journal of Pharmacology and Experimental Therapeutics
  68. Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats
    Débora Fabris, Lídia M. Andrade, Icaro da Silva Freitas, Felipe V. Gomes, Francisco Silveira Guimarães · 2025 · Schizophrenia Research
  69. Additional file 1 of Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice
    Aymen H. Sadaka, Ana G. Ozuna, Richard J. Ortiz, Kulkarni, Praveen, Clare T. Johnson, Heather B. Bradshaw, Bruce S. Cushing, Ai-Ling Li, Andrea G. Hohmann, Ferris, Craig F. · 2021 · Figshare
  70. Stress, Anxiety, and Depression
    Kylie O’Brien, Carolyn Bosak · 2025 · Springer eBooks
  71. Membrane exchangers of inorganic cations at the human blood-brain barrier : focus on lithium transport and TRPVs channels in human brain endothelial cells
    Huilong Luo · 2018 · theses.fr (ABES)
  72. Cannabis
    George F. Koob, Michael A. Arends, Mandy L. McCracken, Michel Le Moal · 2026 · Elsevier eBooks
  73. Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model
    Barkha J. Yadav-Samudrala, Morgan L. Johnson, Ashima Ale, Katherine Xiaofan Jiang, William W. Y. Lee, Amy Nguyen, Dorian Ho, Essie B. Acquah, Isabella C. Orsucci, Laith E. Sawaqed et al. · 2026 · PLoS ONE
  74. The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma
    Farideh A. Javid, Marin Golčić, Anja Harej, Andrej Belančić · 2026 · Pharmacology Research & Perspectives
  75. Angststörungen
    Kylie O’Brien, Philip Blair · 2026 · Springer eBooks
  76. Autismus-Spektrum-Störung
    Kylie O’Brien, Philip Blair · 2026 · Springer eBooks
  77. High cannabidiol oil for the treatment of chronic pain and anxiety: Results from Project Twenty21 Australia
    Kylie O’Brien, Justin Beilby, Michael T. Lynskey, Michael Barnes, Anne Katrin Schlag, David John Nutt · 2026 · Drug Science Policy and Law
  78. PRECLINICAL DEVELOPMENT OF PHYTOCANNABINOID- AND ENDOCANNABINOID- BASED PHARMACOTHERAPIES FOR THE TREATMENT OF ETHANOL-INDUCED NEURODEGENERATION
    Daniel J. Liput · 2013 · UKnowledge (University of Kentucky)